Market Price

108.21 

0.51 0.5%

as of Apr 18 '19

52 Week Range:

88.26 112.31


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

AptarGroup, Inc. provides a range of packaging, dispensing, and sealing solutions primarily for the beauty, personal care, home care, prescription drug, consumer health care, injectable, and food and beverage markets. The company operates through three segments: Beauty + Home, Pharma, and Food + Beverage. The Beauty + Home segment primarily sells pumps, closures, aerosol valves, accessories, and sealing solutions to the personal care and home care markets; and pumps and decorative components components to the beauty market. The Pharma segment provides pumps for nasal allergy treatments; and metered dose inhaler valves for respiratory ailments, such as asthma and chronic obstructive pulmonary diseases in pharmaceutical market; and elastomer for injectable primary packaging components. The Food + Beverage segment offers dispensing and non-dispensing closures, elastomeric flow control components, spray pumps, and aerosol valves to the food and beverage markets. The company also manufactures and sells elastomeric primary packaging components for injectable market, which include stoppers for infusion, antibiotic, lyophilization, and diagnostic vials; and pre-filled syringe components, such as plungers, needle shields, tip caps and cartridges, and dropper bulbs and syringe plungers. AptarGroup, Inc. sells its products through own sales force, as well as independent representatives and distributors in Asia, Europe, Latin America, and North America. The company was founded in 1992 and is headquartered in Crystal Lake, Illinois.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Equity (BVPS) 16.75
18.62
19.15
20.26
20.94
22.33
22.75
18.55
20.71
21.38
22.13
growth rate 11.2% 2.9% 5.8% 3.4% 6.6% 1.9% -18.5% 11.6% 3.2% 3.5%
Earnings BIT 220.97
184.06
254.39
274.94
241.37
264.38
306.42
316.75
318.72
323.73
373.87
growth rate -16.7% 38.2% 8.1% -12.2% 9.5% 15.9% 3.4% 0.6% 1.6% 15.5%
Avg.PE 16.16
19.96
19.16
19.69
20.08
26.88
22.55
24.60
23.99
26.28
32.36
growth rate 23.5% -4.0% 2.8% 2.0% 33.9% -16.1% 9.1% -2.5% 9.6% 23.1%
ROA 8.20
6.58
8.70
8.76
7.25
7.13
7.77
8.18
8.15
7.66
5.98
growth rate -19.8% 32.2% 0.7% -17.2% -1.7% 9.0% 5.3% -0.4% -6.0% -21.9%
ROE 13.64
10.46
13.70
14.30
12.18
12.03
14.84
17.70
17.70
17.70
14.24
growth rate -23.3% 31.0% 4.4% -14.8% -1.2% 23.4% 19.3% 0.0% 0.0% -19.6%
ROIC 10.84
8.86
11.23
11.39
9.81
9.69
10.34
11.19
11.22
10.50
8.08
growth rate -18.3% 26.8% 1.4% -13.9% -1.2% 6.7% 8.2% 0.3% -6.4% -23.1%
Cur. Ratio 2.29
2.26
2.51
2.20
2.28
2.21
2.01
3.14
2.34
3.16
1.93
growth rate -1.3% 11.1% -12.4% 3.6% -3.1% -9.1% 56.2% -25.5% 35.0% -38.9%
Quick Ratio 1.43
1.56
1.73
1.48
1.37
1.38
1.33
2.21
1.66
2.32
1.21
growth rate 9.1% 10.9% -14.5% -7.4% 0.7% -3.6% 66.2% -24.9% 39.8% -47.8%
Leverage 1.62
1.56
1.59
1.67
1.68
1.68
2.21
2.12
2.22
2.39
2.37
growth rate -3.7% 1.9% 5.0% 0.6% 0.0% 31.6% -4.1% 4.7% 7.7% -0.8%
Balance Sheet Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Acct.Receivable 0.00
0.00
357.10
389.02
396.79
438.22
406.98
391.57
433.13
510.43
growth rate 8.9% 2.0% 10.4% -7.1% -3.8% 10.6% 17.9%
Acct.Payable 335.18
380.67
403.05
116.37
115.06
115.51
153.86
growth rate 13.6% 5.9% -71.1% -1.1% 0.4% 33.2%
Cur.Assets 859.70
943.50
1,064.00
1,143.95
1,038.93
1,198.41
1,213.94
1,294.99
1,270.17
1,670.07
growth rate 9.8% 12.8% 7.5% -9.2% 15.4% 1.3% 6.7% -1.9% 31.5%
Total Assets 1,831.80
1,956.20
2,032.70
2,159.30
2,324.41
2,497.76
2,437.19
2,437.05
2,606.79
3,137.82
growth rate 6.8% 3.9% 6.2% 7.7% 7.5% -2.4% 0.0% 7.0% 20.4%
Cash 192.10
333.00
376.40
377.62
229.76
309.86
399.76
489.90
466.29
712.64
growth rate 73.4% 13.0% 0.3% -39.2% 34.9% 29.0% 22.6% -4.8% 52.8%
Inventory 244.80
230.80
272.30
285.16
321.89
353.16
311.07
294.91
296.91
337.22
growth rate -5.7% 18.0% 4.7% 12.9% 9.7% -11.9% -5.2% 0.7% 13.6%
Cur.Liabilities 375.00
417.30
423.30
518.85
455.32
542.82
604.74
411.90
542.96
527.75
growth rate 11.3% 1.4% 22.6% -12.2% 19.2% 11.4% -31.9% 31.8% -2.8%
Liabilities 700.80
703.30
753.80
869.52
944.52
1,018.01
1,333.27
1,287.34
1,432.54
1,825.78
growth rate 0.4% 7.2% 15.4% 8.6% 7.8% 31.0% -3.5% 11.3% 27.5%
LT Debt 226.90
209.60
258.80
254.91
352.86
354.81
588.89
760.85
772.74
1,191.01
growth rate -7.6% 23.5% -1.5% 38.4% 0.6% 66.0% 29.2% 1.6% 54.1%
Equity 1,131.00
1,252.80
1,278.90
1,289.78
1,379.89
1,479.76
1,103.41
1,149.41
1,173.95
1,311.74
growth rate 10.8% 2.1% 0.9% 7.0% 7.2% -25.4% 4.2% 2.1% 11.7%
Common Shares 71.00
70.00
70.00
69.00
68.00
68.00
67.00
64.00
65.00
65.00
65.00
growth rate -1.4% 0.0% -1.4% -1.5% 0.0% -1.5% -4.5% 1.6% 0.0% 0.0%
Cash Flow Statement Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Capital Expenditures -0.60
-1.70
-1.40
179.69
174.05
151.51
161.94
149.32
128.99
156.62
growth rate 0.0% 0.0% 100.0% -3.1% -13.0% 6.9% -7.8% -13.6% 21.4%
Cash Dividends 38.10
40.60
44.50
53.31
58.44
66.13
71.07
71.25
76.66
79.94
growth rate 6.6% 9.6% 19.8% 9.6% 13.2% 7.5% 0.3% 7.6% 4.3%
Cash From OA 270.20
279.80
278.70
261.04
313.89
286.10
316.33
323.76
325.30
324.73
growth rate 3.6% -0.4% -6.3% 20.3% -8.9% 10.6% 2.4% 0.5% -0.2%
FCF per Share 0.93
2.13
2.04
1.45
2.04
2.34
1.82
3.11
2.46
3.60
1.35
growth rate 129.0% -4.2% -28.9% 40.7% 14.7% -22.2% 70.9% -20.9% 46.3% -62.5%
Sale Purchase of Stock -76.52
-35.16
-76.13
36.02
64.76
55.35
73.91
growth rate 0.0% 0.0% 100.0% 79.8% -14.5% 33.5%
FCF 65.00
148.00
142.00
81.00
140.00
133.00
153.00
175.00
196.00
168.00
102.00
growth rate 127.7% -4.1% -43.0% 72.8% -5.0% 15.0% 14.4% 12.0% -14.3% -39.3%
Income Statement Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Sales 2,071.70
1,841.62
2,076.70
2,337.18
2,331.04
2,520.01
2,597.81
2,317.15
2,330.93
2,469.28
growth rate -11.1% 12.8% 12.5% -0.3% 8.1% 3.1% -10.8% 0.6% 5.9%
Op.Income 234.20
0.00
268.00
183.67
162.16
171.11
306.42
316.75
318.72
323.73
373.87
growth rate -100.0% -31.5% -11.7% 5.5% 79.1% 3.4% 0.6% 1.6% 15.5%
IBT 226.70
0.00
254.40
274.94
241.37
264.38
286.30
294.57
280.50
294.83
growth rate -100.0% 8.1% -12.2% 9.5% 8.3% 2.9% -4.8% 5.1%
Net Income 153.50
0.00
173.50
183.67
162.16
171.11
191.66
199.35
205.59
220.03
growth rate -100.0% 5.9% -11.7% 5.5% 12.0% 4.0% 3.1% 7.0%
EPS 2.18
1.79
2.48
2.65
2.38
2.52
2.85
3.09
3.17
3.41
3.00
growth rate -17.9% 38.6% 6.9% -10.2% 5.9% 13.1% 8.4% 2.6% 7.6% -12.0%
Gross Profit 660.40
615.95
697.90
768.90
740.67
811.08
842.54
807.10
835.44
865.10
965.97
growth rate -6.7% 13.3% 10.2% -3.7% 9.5% 3.9% -4.2% 3.5% 3.6% 11.7%

Quarterly Statements

Item Name Dec '17 Mar '18 Jun '18 Sep '18 Dec '18
Earnings BIT 80.89
95.29
101.72
94.87
82.93
growth rate 17.8% 6.7% -6.7% -12.6%
Balance Sheet Dec '17 Mar '18 Jun '18 Sep '18 Dec '18
Acct.Receivable 510.43
586.59
583.50
580.45
growth rate 14.9% -0.5% -0.5%
Acct.Payable 153.86
470.85
502.32
518.83
growth rate 206.0% 6.7% 3.3%
Cur.Assets 1,670.07
1,793.12
1,749.76
1,384.71
growth rate 7.4% -2.4% -20.9%
Total Assets 3,137.82
3,283.69
3,222.26
3,407.00
growth rate 4.7% -1.9% 5.7%
Cash 712.64
741.06
718.09
291.38
growth rate 4.0% -3.1% -59.4%
Inventory 337.22
347.79
343.17
394.26
growth rate 3.1% -1.3% 14.9%
Cur.Liabilities 527.75
566.75
580.88
741.80
growth rate 7.4% 2.5% 27.7%
Liabilities 1,825.78
1,878.92
1,874.74
2,014.94
growth rate 2.9% -0.2% 7.5%
LT Debt 1,191.01
1,199.98
1,182.89
1,131.74
growth rate 0.8% -1.4% -4.3%
Equity 1,311.74
1,404.47
1,347.21
1,391.74
growth rate 7.1% -4.1% 3.3%
Common Shares 0.67
0.67
0.67
0.67
growth rate 0.6% -0.5% 0.6%
Cash Flow Statement Dec '17 Mar '18 Jun '18 Sep '18 Dec '18
Capital Expenditures 35.82
40.02
51.73
53.57
growth rate 11.7% 29.3% 3.6%
Cash Dividends 19.94
19.83
19.98
21.18
growth rate -0.6% 0.8% 6.0%
Cash From OA 59.57
51.02
103.49
55.08
growth rate -14.4% 102.9% -46.8%
Sale Purchase of Stock 7.22
34.88
11.54
growth rate 383.2% -66.9%
FCF 23.75
11.00
51.76
1.51
growth rate -53.7% 370.5% -97.1%
Income Statement Dec '17 Mar '18 Jun '18 Sep '18 Dec '18
Sales 625.90
703.35
710.61
665.78
growth rate 12.4% 1.0% -6.3%
Op.Income 80.89
95.29
101.72
94.87
82.93
growth rate 17.8% 6.7% -6.7% -12.6%
IBT 76.26
81.22
74.90
50.94
growth rate 6.5% -7.8% -32.0%
Net Income 49.51
59.30
55.78
39.00
growth rate 19.8% -5.9% -30.1%
EPS
growth rate
Gross Profit 214.68
247.53
246.48
233.68
238.28
growth rate 15.3% -0.4% -5.2% 2.0%
R&D
growth rate

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

F (13.94)

YOY Growth Grade:

E (29.82)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

PE and EPS

Historical Current Forward
PE 36.07 36.07 22.64
EPS / Growth 5.8% 3.00 10.0%

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 2.5%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 2.5% 6.1% 6.1%
Future PE 5.00 23.63 23.63
Future EPS 3.84 5.42 5.42
Value Price
MOS %
4.75
-95.6%
31.65
-70.8%
31.65
-70.8%
MOS Price 2.37 15.82 15.82
IRT 25.56 18.98 18.98

Graham Number:

NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.